checkAd
    Startseite > Aktien > Genmab > Nachrichten
    Genmab Aktie
    258,40
     
    EUR
    -1,34 %
    -3,50 EUR
    Letzter Kurs 07.06.24 Tradegate
    257,40
     
    EUR
    5 STK
    Geldkurs 07.06.24
    259,30
     
    EUR
    5 STK
    Briefkurs 07.06.24
    ISIN: DK0010272202 · WKN: 565131 · SYM: GE9 · Dänemark ·

    Neueste Nachrichten

    Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
    05.06.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    03.06.24 · globenewswire · Genmab
    Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
    03.06.24 · globenewswire · Genmab
    Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
    02.06.24 · globenewswire · Genmab
    Investigational Acasunlimab (DuoBody -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
    01.06.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    27.05.24 · globenewswire · Genmab
    Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
    23.05.24 · globenewswire · Genmab
    Genmab Completes Acquisition of ProfoundBio
    21.05.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    21.05.24 · globenewswire · Genmab
    Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
    14.05.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    13.05.24 · globenewswire · Genmab
    Capital Increase in Genmab as a Result of Employee Warrant Exercise
    07.05.24 · globenewswire · Genmab